23andMe Holding Co.
NASDAQ:ME
23andMe Holding Co.
NASDAQ:ME
Price:
0.5452 USD
-2.33%
Market Closed
Updated:
Jun 2, 2024
23andMe Holding Co.
Accrued Liabilities
|
23andMe Holding Co.
Accrued Liabilities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
23andMe Holding Co.
NASDAQ:ME
|
Accrued Liabilities
$72.6m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Accrued Liabilities
$1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accrued Liabilities
$153m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Accrued Liabilities
$24.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
Cigna Corp
NYSE:CI
|
Accrued Liabilities
$8.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accrued Liabilities
$820.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
9%
|
See Also
What is 23andMe Holding Co.'s Accrued Liabilities?
Accrued Liabilities
72.6m
USD
72.6m
USD
Based on the financial report for Mar 31, 2023, 23andMe Holding Co.'s Accrued Liabilities amounts to 72.6m USD.
What is 23andMe Holding Co.'s Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
20%
20%
Over the last year, the Accrued Liabilities growth was 44%. The average annual Accrued Liabilities growth rates for 23andMe Holding Co. have been 20% over the past three years .
You don't have any saved screeners yet
